Lynparza Clinical Trials
Here are the 6 most popular medical studies for lynparza
Angiogenesis Inhibitor
Cediranib + Olaparib for Cancer
Recruiting1 awardPhase 2
La Jolla, California
This trial is testing a combination of two drugs to treat patients with solid tumors. Cediranib maleate blocks enzymes needed for cell growth, and olaparib may make the tumor more sensitive to Cediranib maleate.
PD-L1 Inhibitor
Durvalumab + Olaparib + Cediranib for Ovarian Cancer
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing the combination of Durvalumab, Olaparib, and Cediranib in adults with advanced or recurrent ovarian cancer to see how well they tolerate it and if it is effective in treating the cancer.
Popular filter options for lynparza trials
Phase 3 Clinical Trials
View 99 phase 3 medical studies.
Chemotherapy
Olaparib for Metastatic Breast Cancer
Recruiting2 awardsPhase 3
San Diego, California
This trial will compare the effectiveness and safety of olaparib to standard chemotherapy in treating breast cancer that has spread to other parts of the body and has a mutation in the BRCA1 or BRCA2 gene.
PARP Inhibitor
Cediranib + Olaparib for Recurrent Ovarian Cancer
Recruiting1 awardPhase 2 & 3
Greenbrae, California
This trial is testing two drugs, cediranib and olaparib, to see if they work better than standard chemotherapy in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has returned after treatment or continued to grow during treatment.
PARP Inhibitor
Olaparib vs. Cediranib + Olaparib for Recurrent Ovarian Cancer
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial is comparing two different treatments for ovarian, fallopian tube, or primary peritoneal cancer that has come back. One treatment is a standard chemotherapy treatment, and the other is a new treatment that uses two drugs, olaparib and cediranib maleate. The trial will see if the new treatment is more effective than the standard chemotherapy treatment.
Clinical Trials With No Placebo
View 99 medical studies that do not have a placebo group.
Chemotherapy
Olaparib for Metastatic Breast Cancer
Recruiting2 awardsPhase 3
San Diego, California
This trial will compare the effectiveness and safety of olaparib to standard chemotherapy in treating breast cancer that has spread to other parts of the body and has a mutation in the BRCA1 or BRCA2 gene.
PARP Inhibitor
Olaparib + Temozolomide for Sarcoma
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial is testing the safety of an investigational drug combo and what dose is appropriate. The drugs in the combo work by interfering with cancer cells' ability to repair DNA and thus continue dividing.
PARP Inhibitor
Olaparib +2 More for Ovarian Cancer
Recruiting3 awardsPhase 1 & 2
Edmonds, Washington
The purpose of this study is to determine the maximum tolerated dose (MTD) of the investigational agent, olaparib, to give in combination with carboplatin and paclitaxel in patients with relapsed ovarian cancer or uterine cancer. Furthermore, the investigators intend to study the safety and tolerability of the study treatment, response to treatment, time to disease progression, and overall survival.
Angiogenesis Inhibitor
Cediranib + Olaparib for Ovarian and Breast Cancer
Recruiting1 awardPhase 1 & 2
Los Angeles, California
This trial is testing the side effects and best dose of two drugs, cediranib and olaparib, compared to olaparib alone, in treating patients with recurrent ovarian, fallopian tube, peritoneal, or triple-negative breast cancer.
View More Lynparza Trials
See another 82 medical studies focused on lynparza.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.